pH-Dependent Grafting of Cancer Cells with Antigenic Epitopes Promotes Selective Antibody-Mediated Cytotoxicity

Janessa Wehr1, Eden L Sikorski1, Elizabeth Bloch1

  • 1Department of Chemistry, Lehigh University, Bethlehem, Pennsylvania 18015, United States.

Insights

This study introduces novel immuno-engager agents that target solid tumors by exploiting tumor acidity, enabling broader cancer immunotherapy applications. These agents harness the pH-Low Insertion Peptide (pHLIP) to engage immune cells for cancer cell destruction.

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Current immunotherapies face limitations due to the lack of universal cancer biomarkers.
  • Targeting specific tumor markers restricts treatment to a small patient subgroup.

Purpose of the Study:

  • To develop a novel class of cancer therapeutics that target solid tumors universally.
  • To exploit the unique acidic tumor microenvironment for selective cancer cell targeting.

Main Methods:

  • Designed immuno-engager agents utilizing the pH-Low Insertion Peptide (pHLIP) for pH-dependent tumor cell surface anchoring.
  • Conjugated pHLIP with antigens to create targeted epitopes.
  • Assessed the ability of pHLIP-antigen conjugates to recruit immune cells and induce cytotoxicity.

Main Results:

  • pHLIP-antigen conjugates selectively grafted cancer cells in a pH-dependent manner.
  • These conjugates effectively recruited antibodies to the cancer cell surface.
  • Demonstrated induction of cytotoxicity by peripheral blood mononuclear cells and engineered NK cells.

Conclusions:

  • The developed agents offer a promising approach for treating a wide range of solid tumors.
  • This strategy circumvents limitations associated with narrow tumor biomarker selectivity.
  • Exploiting tumor acidity provides a universal targeting mechanism for immunotherapy.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
83.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.0K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
877